![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Immune Thrombocytopenia - 34 Studies Found
Not yet recruiting |
: A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP) : Immune Thrombocytopenia : 2016-12-22 : Drug: Bortezomib Bortezomib was given by intravenous bolus injection at a dose of 1.3 mg/m2 on days 1, 4 |
Recruiting |
: A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia : Immune Thrombocytopenia : 2012-03-29 : Drug: Decitabine Decitabine 3.5mg/m2,ivdrip,qd x 3d, every four weeks for one cycle. It wi |
Recruiting |
: Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia : Immune Thrombocytopenia : 2017-01-16 :
|
Withdrawn |
: The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia : Immune Thrombocytopenia : 2013-04-03 |
Recruiting |
: Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia : Immune Thrombocytopenia : 2014-11-17 :
|
Recruiting |
: End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia : Immune Thrombocytopenia : 2011-06-13 : Drug: Discontinuation of eltrombopag Observation of subjects as they discontinue the use of eltrombopag |
Withdrawn |
: A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP) : Immune Thrombocytopenia : 2014-07-27 :
|
Completed |
: An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP) : Immune Thrombocytopenia : 2014-05-29 :
|
Active, not recruiting |
: Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP) : Immune Thrombocytopenia : 2014-11-06 : Other: blood sample |
Completed |
: An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia : Immune Thrombocytopenia : 2014-02-13 : Drug: Human immunoglobulin intravenous After GC5107A Intravenous injection, evaluate platelet increase |